CyberArk Unveils First-Of-Its-Kind Machine Identity Security Solution To Secure Workloads Across Every Environment
10.4.2025 15:00:00 CEST | Business Wire | Press release
Platform delivers the industry's most comprehensive protection for all non-human identities that matterCombines the application of unique and universal identities to all workloads with secrets management, reducing machine identity complexity and riskNew discovery capabilities to provide contextual understanding of workload identity risk
CyberArk (NASDAQ: CYBR), the global leader in identity security, today announced the availability of CyberArk Secure Workload Access Solution,1 delivering the industry's most comprehensive protection for all non-human identities that matter. The solution will enable security teams to gain visibility and control over the entire machine identity lifecycle, from creation and governance to automated rotation and renewal.
Machine identities proliferate in cloud-native architectures, including applications, workloads, and automated processes. Unlike solutions focusing on singular machine identity types, CyberArk's layered approach will enable organizations to enforce least privilege, mitigate risk, and prevent credential-based attacks for all workloads across hybrid and multi-cloud environments.
In addition, CyberArk has extended its discovery and context capabilities, designed to help security teams take the first steps to modernize workload authentication by assessing, understanding and eliminating risks tied to unprotected machine identities. These automated capabilities help teams generate an inventory of secrets, certificates and information about their environment, understand the risk of compromise tied to each machine identity and prioritize mitigation actions.
"Modern, cloud and ephemeral workloads mean authentication can be fragmented, making access control challenging and resulting in a large, unprotected attack surface that dramatically increases the risk of breaches," said Kurt Sand, GM of Machine Identity Security at CyberArk. "Recent high-profile attacks have highlighted the urgent need for a modern, identity-first model that enforces universal and unique workload identities to help organizations confidently secure workloads across their entire hybrid and multi-cloud estate."
The core of the Secure Workload Access Solution is CyberArk Workload Identity Manager. This lightweight, distributed, and cloud-native machine identity issuer goes beyond traditional Public Key Infrastructure (PKI) systems that cannot scale to the needs of ephemeral cloud workloads. The new solution will integrate Workload Identity Manager with CyberArk Secrets Manager, enabling secure access for all workloads as cloud-native and containerized environments grow.
The CyberArk Secure Workload Access Solution will allow workloads running in virtualized environments to be automatically identified for access to cloud services and cloud provider environments, securing dynamic, cloud-native workloads like Kubernetes and service mesh. It will provide the capability to:
- Securely connect on-premises and cloud workloads across environments with unique and universal SPIFFE2 identities that work with existing identities, applications, clouds and SaaS services.
- Integrate seamlessly with secrets management for existing API key and access token authentication, as well as other secrets.
- Discover and assess risk across all workloads, making it easier to detect threats, enforce security policies and prevent unauthorized access.
Further information:
- Learn more about the CyberArk Secure Workload Access Solution
- Join CyberArk's Secure Workload Access Partner Program
- Blog: CyberArk's Vision to Pioneer Secure Access for Workloads
- Blog:Discovery Alone Is Not Enough: You Need Context to Secure Machine Identities
1The CyberArk Secure Workload Access Solution is currently in early availability. An early availability program enables select customers to access technologies before they become generally available.
2Secure Production Identity Framework For Everyone (SPIFFE).
About CyberArk
CyberArk (NASDAQ: CYBR) is the global leader in identity security, trusted by organizations around the world to secure human and machine identities in the modern enterprise. CyberArk's AI-powered Identity Security Platform applies intelligent privilege controls to every identity with continuous threat prevention, detection and response across the identity lifecycle. With CyberArk, organizations can reduce operational and security risks by enabling zero trust and least privilege with complete visibility, empowering all users and identities, including workforce, IT, developers and machines, to securely access any resource, located anywhere, from everywhere. Learn more at cyberark.com.
Copyright © 2025 CyberArk Software. All Rights Reserved. All other brand names, product names, or trademarks belong to their respective holders.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250410235752/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease1.5.2026 23:28:00 CEST | Press release
Jakafi XR is a once-daily, film-coated, extended-release formulation of Jakafi®(ruxolitinib)Once-daily Jakafi XR was shown to provide consistent, day-long exposure comparable to twice-daily JakafiJakafi XR will be available for pharmacy orders by May 8 Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™ (ruxolitinib) extended-release tablets for the treatment of adults with intermediate- or high-risk myelofibrosis (MF); adults with polycythemia vera (PV) who have had an inadequate response to or are intolerant of hydroxyurea; as well as adults and children aged 12 years and older with steroid-refractory acute graft-versus-host disease (GVHD) or chronic GVHD after failure of one or two lines of systemic therapy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260501334677/en/ “The approval of Jakafi XR reinforces Incyte’s leadership in hematology and our focus on meetin
Barilla Hosts Surprise Formula 1® Family Reunion Dinner During Miami Race Weekend1.5.2026 18:08:00 CEST | Press release
Drivers and team members of Formula 1® were reunited with their loved ones during a night that also celebrated the new partnership between Barilla and the Visa Cash App Racing Bulls Formula 1® Team. A special invitation, a table, and a plate of pasta shared by people who are often apart. That’s all it took for Barilla to bring the spirit of togetherness to Miami during the opening day of the FORMULA 1® CRYPTO.COM MIAMI GRAND PRIX 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430832316/en/ Barilla hosts Arvid Lindblad, Mikaela Shiffrin, and Nico Rosberg with Chef Massimo Bottura at Torno Subito, where the Formula 1® community came together for a surprise dinner. Barilla, the Official Pasta Partner of Formula 1®, welcomed team members and their families to Torno Subito Miami, the restaurant by three-Michelin-starred Chef Massimo Bottura, with the kitchen led by Chef Bernardo Paladini, for an evening where engines wer
TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health1.5.2026 12:07:00 CEST | Press release
Time Magazine has named pioneering medical technology company Xenco Medical as one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health. Widely regarded as the most prestigious recognition in business and technology, being selected to the TIME100 List remains the most coveted accolade that a company can achieve globally. The TIME100 Impact Awards are given to only 5 recipients each year, making it the rarest of honors that a company can receive and a profound recognition of transformative, global impact. Xenco Medical was honored by Time as the sole recipient of the TIME100 Impact Award in Health in 2026, signifying its leading, global distinction in impact on healthcare. According to Time Magazine, the TIME100 Most Influential Companies list highlights “companies making an extraordinary impact around the world.” The honor bestowed by Time comes after Xenco Medical was named the 2025 Medical Device/ Diagnostics Company of the
Andersen Consulting styrker sine kompetencer inden for digital transformation med Weexa1.5.2026 10:07:00 CEST | Pressemeddelelse
Andersen Consulting indgår en samarbejdsaftale med Weexa, en global leverandør af løsninger inden for digital transformation, B2B-integration og digitalisering af forsyningskæden. Med hovedsæde i Frankrig leverer Weexa end-to-end-tjenester, der hjælper organisationer med at optimere, sikre og skalere deres digitale økosystemer. Virksomheden specialiserer sig i styring af B2B-datastrømme og digitalisering, hvilket muliggør problemfri kommunikation mellem applikationer både internt og på tværs af organisationer gennem teknologier som EDI, API'er og e-fakturering. Weexa tilbyder også SAP-integration og supply chain-løsninger til styring af lager og transport, sideløbende med strategisk rådgivning, projektlevering og vedligeholdelse af tredjepartsapplikationer. Weexa betjener organisationer inden for fødevaresektoren, detailhandel, engros, logistik, transport, bilindustrien, sundheds- og mediesektoren og hjælper globale virksomheder med at optimere deres ydeevne samt at overholde de nyeste
Inspirit Capital Completes Acquisition of Kaplan Languages Group1.5.2026 01:17:00 CEST | Press release
Inspirit Capital, a specialist investor in corporate carve-outs, and Kaplan, the global education company, have announced the completion of Inspirit’s acquisition of Kaplan Languages Group (KLG) from Kaplan. Financial terms are not being disclosed. KLG, a leading global language education platform, comprises Kaplan International Languages, Alpadia Language Schools, Azurlingua, and ESL Education. Inspirit Capital will support KLG in delivering on its ambitious growth plans, whilst continuing its fundamental mission to transform lives through language education. The next phase of ownership will see the development and launch of a refreshed standalone brand identity for KLG, with further announcements to follow on this in due course. KLG will continue to use the Kaplan name under a transitional license from Kaplan, Inc. until a new brand is announced. About Kaplan Languages Group Since 2006, KLG has provided the highest quality language education and cultural immersion experiences. Kaplan
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom